Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 7/20 | 0.44 |
| ▸ | CASR | P41180 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11974253 | 0.90 | CNR2 (0.48) | CNR2CASREGFRERBB2SMN1; SMN2 | |
| SCHEMBL4876985 | 0.88 | CNR2 (0.52) | CNR2CASREGFRERBB2SMN1; SMN2 | |
| SCHEMBL14496272 | 0.86 | CNR2 (0.54) | CNR2CASREGFRERBB2SMN1; SMN2 | |
| SCHEMBL12056655 | 0.82 | EGFR (0.46) | CNR2CASREGFRERBB2SMN1; SMN2 | |
| SCHEMBL655214 | 0.77 | CNR2 (0.49) | CNR2EGFRERBB2TSHRALDH1A1 | |
| SCHEMBL7153351 | 0.76 | EGFR (0.50) | CNR2EGFRERBB2L3MBTL1TSHR | |
| SCHEMBL20066465 | 0.75 | CNR2 (0.47) | CNR2CASREGFRERBB2L3MBTL1 | |
| SCHEMBL1459455 | 0.74 | EGFR (0.44) | CNR2EGFRERBB2L3MBTL1TSHR | |
| SCHEMBL3901022 | 0.74 | CNR2 (0.44) | CNR2EGFRERBB2 | |
| SCHEMBL11225823 | 0.74 | CNR2 (0.50) | CNR2EGFRERBB2SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130065849-A1 | BIPHOTONIC PHOTOSENSITIZERS, NANOPARTICLES CONTAINING THE SAME AND THEIR USE AS DRUGS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065849-A1 | BIPHOTONIC PHOTOSENSITIZERS, NANOPARTICLES CONTAINING THE SAME AND THEIR USE AS DRUGS | CCNB1, ABCB1, CA6 | CNR2 552/4885CASR 3229/4885EGFR 456/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.